RFG Advisory LLC Takes Position in Zoetis Inc. (NYSE:ZTS)

RFG Advisory LLC acquired a new position in Zoetis Inc. (NYSE:ZTS) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,812 shares of the company’s stock, valued at approximately $307,000.

Other hedge funds have also recently bought and sold shares of the company. Blue Bell Private Wealth Management LLC boosted its position in Zoetis by 222.5% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 129 shares of the company’s stock worth $25,000 after acquiring an additional 89 shares during the period. Independence Bank of Kentucky grew its position in Zoetis by 371.4% in the 4th quarter. Independence Bank of Kentucky now owns 165 shares of the company’s stock valued at $33,000 after buying an additional 130 shares in the last quarter. Private Wealth Management Group LLC bought a new position in Zoetis in the 4th quarter valued at about $33,000. Ramirez Asset Management Inc. acquired a new position in Zoetis during the 3rd quarter valued at about $35,000. Finally, Gladius Capital Management LP bought a new stake in shares of Zoetis during the 4th quarter worth about $40,000. 92.80% of the stock is currently owned by institutional investors.

Insider Activity

In other news, EVP Roxanne Lagano sold 923 shares of Zoetis stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $151.17, for a total transaction of $139,529.91. Following the transaction, the executive vice president now owns 14,800 shares in the company, valued at $2,237,316. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.16% of the company’s stock.

Wall Street Analysts Forecast Growth

ZTS has been the topic of a number of research analyst reports. Piper Sandler reiterated an “overweight” rating and set a $195.00 price objective (down previously from $220.00) on shares of Zoetis in a research note on Tuesday, April 16th. HSBC lowered their price target on Zoetis from $230.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. The Goldman Sachs Group cut their price objective on Zoetis from $223.00 to $196.00 and set a “buy” rating for the company in a report on Monday, May 6th. Stifel Nicolaus lowered their target price on Zoetis from $195.00 to $180.00 and set a “buy” rating on the stock in a report on Tuesday, April 30th. Finally, Barclays cut their price target on shares of Zoetis from $260.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 23rd. Eight research analysts have rated the stock with a buy rating, According to MarketBeat, Zoetis currently has an average rating of “Buy” and a consensus target price of $211.75.

Zoetis Trading Down 2.3 %

Shares of NYSE ZTS opened at $167.92 on Wednesday. The company has a quick ratio of 1.94, a current ratio of 3.33 and a debt-to-equity ratio of 1.30. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $201.92. The company has a market cap of $76.62 billion, a price-to-earnings ratio of 32.35, a P/E/G ratio of 2.67 and a beta of 0.88. The business has a fifty day simple moving average of $167.30 and a 200-day simple moving average of $179.00.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Thursday, May 2nd. The company reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.34 by $0.04. Zoetis had a net margin of 27.38% and a return on equity of 50.34%. The company had revenue of $2.19 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. The business’s quarterly revenue was up 9.5% on a year-over-year basis. Sell-side analysts predict that Zoetis Inc. will post 5.76 EPS for the current year.

Zoetis Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 4th. Shareholders of record on Thursday, July 18th will be paid a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a yield of 1.03%. The ex-dividend date is Thursday, July 18th. Zoetis’s dividend payout ratio (DPR) is currently 33.33%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.